Breaking News Instant updates and real-time market news.

DGLY

Digital Ally

$5.41

-0.12 (-2.17%)

, TASR

Changed name to AAXN

$22.09

-0.4 (-1.78%)

07:32
10/14/16
10/14
07:32
10/14/16
07:32

Digital Ally receives favorable ruling in suit against TASER

Digital Ally (DGLY) announced that on October 13, the Federal District Court issued a ruling that denied the request of Taser International (TASR) to continue the stay of discovery on the Antitrust claims included in Digital Ally's lawsuit against Taser. The ruling allows Digital Ally to commence discovery, which eventually will include requests for production of documents, interrogatories, and depositions of Taser employees, former employees and consultants. The ruling also will also allow Digital Ally to undertake discovery of Taser's customers beginning with subpoenas, production of documents and, in time, depositions of the customer's employees, former employees, officials and consultants. Taser has filed a motion to dismiss the antitrust claims in the lawsuit that is still pending before the court. In addition, Taser previously received a stay of all discovery related to the antitrust claim portion of the lawsuit. With this ruling, the court has now lifted that stay and Digital Ally is now free to commence such discovery.

DGLY

Digital Ally

$5.41

-0.12 (-2.17%)

TASR

Changed name to AAXN

$22.09

-0.4 (-1.78%)

DGLY Digital Ally
$5.41

-0.12 (-2.17%)

11/13/15
11/13/15
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abbott (ABT) downgraded to Neutral from Buy at Goldman... Advance Auto Parts (AAP) downgraded after Q3 miss at Sterne Agee CRT... CafePress (PRSS) downgraded to Underperform from Market Perform at Raymond James... Ctrip.com (CTRP) downgraded to Outperform from Strong Buy at Raymond James... CubeSmart (CUBE) downgraded to Outperform from Strong Buy at Raymond James... Deutsche Bank (DB) downgraded to Neutral from Buy at Citi... Digital Ally (DGLY) downgraded to Neutral from Buy at Roth Capital... El Pollo Loco (LOCO) downgraded to Neutral at Baird... F5 Networks (FFIV) downgraded to Market Perform from Outperform at William Blair... FirstMerit (FMER) downgraded on stock outperformance at Raymond James... Fly Leasing (FLY) downgraded to Underweight from Neutral at JPMorgan... GameStop (GME) downgraded on valuation, digital impact at Pacific Crest... Histogenics (HSGX) downgraded to Neutral from Buy at BTIG... MaxPoint (MXPT) downgraded to Hold from Buy at Needham... Memorial Resource (MRD) downgraded to Outperform at Scotia Howard Weil... Rite Aid (RAD) downgraded to Neutral from Overweight at JPMorgan... Rubicon Minerals (RBY) downgraded to Sell from Hold at Canaccord... SABMiller (SBMRY) downgraded to Hold from Buy at Berenberg... Sensata (ST) downgraded at SunTrust... Stryker (SYK) downgraded to Neutral from Buy at Goldman.
08/05/16
08/05/16
NO CHANGE

Digital Ally reports Q2 non-GAAP EPS (45c), consensus (20c)
Reports Q2 revenue $4.4M, consensus $5.75M.
08/18/16
MAXM
08/18/16
INITIATION
Target $15
MAXM
Buy
Digital Ally initiated with a Buy at Maxim
Maxim analyst Brian Kinstlinger initaited Digital Ally with a Buy and $15 price target saying the company will benefit from the surging demand for body-worn cameras.
08/18/16
08/18/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Barnes & Noble (BKS) initiated with a Neutral at Sidoti. 2. Digital Ally (DGLY) initiated with a Buy at Maxim. 3. Korn/Ferry (KFY) initiated with a Hold at Deutsche Bank. 4. Phillips 66 Partners (PSXP) initiated with a Buy at Stifel. 5. Arrowhead (ARWR) initiated with a Buy at Cantor. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TASR Changed name to AAXN
$22.09

-0.4 (-1.78%)

10/05/16
OPCO
10/05/16
NO CHANGE
OPCO
Perform
TASER competitor deal with NYPD should not set any precedent, says Oppenheimer
Oppenheimer analyst Andrew Uerkwitz believes Vievu's body camera contract with NYPD could result in some pricing pressure over time but should not set any precedents. The analyst notes that it was expected that TASER "can't win them all," and points out that the economics of the deal are a "sober reminder" that storage costs are as key as service and functionality. Uerkwitz expects TASER to shift the conversation toward innovation, additional services/opportunities, and leverage going forward. He reiterates a Perform rating on TASER's shares.
10/06/16
JPMS
10/06/16
NO CHANGE
JPMS
Overweight
TASER selloff overdone, says JPMorgan
10/06/16
JPMS
10/06/16
NO CHANGE
Target $31
JPMS
Overweight
NYPD contract fuels concerns, but TASER selloff overdone, says JPMorgan
JPMorgan analyst Mark Strouse notes that TASER's stock has declined significantly this week owing largely to the reported loss of the NYPD body-camera contract to a competitor. While the analyst sees this loss as somewhat of a surprise, he thinks the contract's pricing was the largest factor weighing on the stock. However, Strouse believes the NYPD contract pricing was a one-off occurrence. The analyst sees the selloff in TASER's shares as overdone and recommends investors add to positions. He reiterates an Overweight rating and $31 price target on the shares.
10/14/16
IMPC
10/14/16
INITIATION
Target $27
IMPC
Outperform
TASER initiated with an Outperform at Imperial Capital
Imperial Capital analyst Jeff Kessler started TASER with an Outperform rating and $27 price target. The company's "unaided" brand awareness and "very high" market share provide "significant leading advantage" over competitors in non-lethal weaponry space, Kessler tells investors in a research note.

TODAY'S FREE FLY STORIES

ALNY

Alnylam

$113.84

38.8 (51.71%)

08:05
09/21/17
09/21
08:05
09/21/17
08:05
Recommendations
Alnylam analyst commentary  »

Alnylam data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:05
09/21/17
09/21
08:05
09/21/17
08:05
General news
Canada wholesale trade report preview »

Canada wholesale trade…

BHGE

Baker Hughes

$37.50

0.11 (0.29%)

08:04
09/21/17
09/21
08:04
09/21/17
08:04
Recommendations
Baker Hughes analyst commentary  »

Baker Hughes 2018…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 20

    Oct

SCG

Scana

$57.80

-0.41 (-0.70%)

08:04
09/21/17
09/21
08:04
09/21/17
08:04
Hot Stocks
Scana receives subpoena for documents relating to nuclear project »

Scana announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TANH

Tantech Holdings

$4.07

0.08 (2.01%)

08:03
09/21/17
09/21
08:03
09/21/17
08:03
Hot Stocks
Tantech Holdings awarded $20M in electric van and bus sales orders »

Tantech Holdings'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VR

Validus

$46.93

1.2 (2.62%)

08:03
09/21/17
09/21
08:03
09/21/17
08:03
Recommendations
Validus analyst commentary  »

Validus net exposure to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOLD

Audentes Therapeutics

$26.57

1.04 (4.07%)

08:02
09/21/17
09/21
08:02
09/21/17
08:02
Hot Stocks
Audentes Therapeutics doses first patient in ASPIRO trial »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELGX

Endologix

$4.29

-0.15 (-3.38%)

08:01
09/21/17
09/21
08:01
09/21/17
08:01
Hot Stocks
Endologix announces CE Mark approval for Nellix system »

Endologix announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$156.07

-2.66 (-1.68%)

08:00
09/21/17
09/21
08:00
09/21/17
08:00
Options
Apple call buyer realizes 32% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

08:00
09/21/17
09/21
08:00
09/21/17
08:00
General news
Treasury Market Outlook: bonds remain mostly weaker »

Treasury Market Outlook:…

NVDA

Nvidia

, TSLA

Tesla

07:58
09/21/17
09/21
07:58
09/21/17
07:58
Technical Analysis
Technical View: AMD trades up on report it is working with Tesla on AI chip »

In the pre-market the AMD…

NVDA

Nvidia

TSLA

Tesla

AMD

AMD

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

JAKK

JAKKS Pacific

$3.15

0.325 (11.50%)

07:56
09/21/17
09/21
07:56
09/21/17
07:56
Downgrade
JAKKS Pacific rating change  »

JAKKS Pacific downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCL

Royal Caribbean

$114.94

-2.98 (-2.53%)

07:56
09/21/17
09/21
07:56
09/21/17
07:56
Conference/Events
Royal Caribbean management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RMBS

Rambus

$13.35

-0.23 (-1.69%)

07:55
09/21/17
09/21
07:55
09/21/17
07:55
Conference/Events
Rambus to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Oct

MO

Altria Group

$61.22

-1.01 (-1.62%)

07:54
09/21/17
09/21
07:54
09/21/17
07:54
Recommendations
Altria Group analyst commentary  »

Altria cigarette price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$136.77

0.03 (0.02%)

07:50
09/21/17
09/21
07:50
09/21/17
07:50
Conference/Events
Moody's management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

LII

Lennox

$170.37

4.54 (2.74%)

07:49
09/21/17
09/21
07:49
09/21/17
07:49
Conference/Events
Lennox management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 26

    Sep

APRN

Blue Apron

$5.22

-0.29 (-5.26%)

07:49
09/21/17
09/21
07:49
09/21/17
07:49
Technical Analysis
Technical View: Blue Apron trades highe as Plated acquired by Albertsons »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIVI

II-VI

07:48
09/21/17
09/21
07:48
09/21/17
07:48
Conference/Events
II-VI management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 28

    Sep

  • 13

    Nov

HSC

Harsco

$19.70

-0.2 (-1.01%)

07:47
09/21/17
09/21
07:47
09/21/17
07:47
Conference/Events
Harsco management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

TXN

Texas Instruments

$85.83

-0.98 (-1.13%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$438.17

6.79 (1.57%)

, AMGN

Amgen

$188.17

1.85 (0.99%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Regeneron, Amgen, AstraZeneca, AbbVie analyst commentary  »

Regeneron price target…

REGN

Regeneron

$438.17

6.79 (1.57%)

AMGN

Amgen

$188.17

1.85 (0.99%)

AZN

AstraZeneca

$32.93

0.26 (0.80%)

ABBV

AbbVie

$87.41

1.04 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 25

    Sep

  • 27

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

ALNY

Alnylam

$113.84

38.8 (51.71%)

07:44
09/21/17
09/21
07:44
09/21/17
07:44
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHF

Brighthouse Financial

$57.49

0.56 (0.98%)

07:43
09/21/17
09/21
07:43
09/21/17
07:43
Initiation
Brighthouse Financial initiated  »

Brighthouse Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$26.29

-1.42 (-5.12%)

07:42
09/21/17
09/21
07:42
09/21/17
07:42
Technical Analysis
Technical View: JinkoSolar slips in early trading, analyst action »

Shares were last down 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.